TY - JOUR
T1 - Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark
AU - Villumsen, Steen
AU - Jørgensen, Charlotte Sværke
AU - Smith, Birgitte
AU - Uldum, Søren
AU - Schiellerup, Peter
AU - Krogfelt, Karen Angeliki
PY - 2009/10
Y1 - 2009/10
N2 - Q fever is a ubiquitous zoonosis caused by Coxiella burnetii. The disease is emerging in many parts of the world, likely because of increased awareness and availability of better diagnostics. The diagnosis is primarily based on serology. Because the prevalence of the disease varies worldwide, the establishment of local cutoff values is needed. A baseline for antibodies against C. burnetii in Denmark was defined by testing sera from healthy Danish volunteers using a commercially available immunofluorescence antibody test. Cross-reactivity was studied on sera obtained from patients experiencing clinically related diseases. The cutoff titers suggested by the manufacturer were found to result in very low specificity of the test. The specificity was, however, effectively increased by using cutoff titers based on the local baseline and equal to immunoglobulin M (IgM) phase I ≥128, IgM phase II ≥256, IgG phase I ≥512, and IgG phase II ≥1024.
AB - Q fever is a ubiquitous zoonosis caused by Coxiella burnetii. The disease is emerging in many parts of the world, likely because of increased awareness and availability of better diagnostics. The diagnosis is primarily based on serology. Because the prevalence of the disease varies worldwide, the establishment of local cutoff values is needed. A baseline for antibodies against C. burnetii in Denmark was defined by testing sera from healthy Danish volunteers using a commercially available immunofluorescence antibody test. Cross-reactivity was studied on sera obtained from patients experiencing clinically related diseases. The cutoff titers suggested by the manufacturer were found to result in very low specificity of the test. The specificity was, however, effectively increased by using cutoff titers based on the local baseline and equal to immunoglobulin M (IgM) phase I ≥128, IgM phase II ≥256, IgG phase I ≥512, and IgG phase II ≥1024.
U2 - 10.1016/j.diagmicrobio.2009.06.004
DO - 10.1016/j.diagmicrobio.2009.06.004
M3 - Journal article
SN - 0732-8893
VL - 65
SP - 93
EP - 98
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
IS - 2
ER -